Complementary and Alternative Medicine for Diabetes

Diabetes Canada Clinical Practice Guidelines Expert Committee

Loren D. Grossman MD, FRCPC, FACP, Robert Roscoe BScPharm, ACPR, CDE, CPT, Anita R. Shack BFA, DC, FATA

  • Key Messages
  • Recommendations
  • Figures
  • Full Text
  • References

Key Messages

  • Anywhere from 25% to 57% of people with diabetes report using complementary or alternative medicine.
  • Some natural health products have shown a lowering of A1C by ≥0.5% in trials lasting at least 3 months in adults with type 2 diabetes, but most are single, small trials that require further large-scale evaluations before they can be recommended for widespread use in diabetes.
  • A few more commonly used natural health products for diabetes have been studied in larger randomized controlled trials and/or meta-analyses refuting the popular belief of benefit of these compounds.
  • Health-care providers should always ask about the use of complementary and alternative medicine as some may result in unexpected side effects and/or interactions with traditional pharmacotherapies.

Key Messages for People with Diabetes

  • Many people with diabetes use complementary medicine (along with) or alternative medicine (instead of) with conventional medications for diabetes.
  • Although some of these therapies may have the potential to be effective, they have not been sufficiently studied and others can be ineffective or even harmful.
  • It is important to let your health-care providers know if you are using complementary and/or alternative medicine for your diabetes.

Introduction

Despite advances in the management of type 1 and type 2 diabetes, therapeutic targets are often not met. People dissatisfied with conventional medicine often turn to nontraditional alternatives. Complementary and alternative medicine (CAM) can be loosely defined as health-care approaches developed outside of mainstream Western, or conventional medicine, with “complementary” meaning used together with, and “alternative” meaning used in place of conventional medicine (1). According to a report from the Fraser Institute, 50% to 79% of Canadians had used at least 1 CAM sometime in their lives, based on surveys from 1997, 2006 and 2016 (2). The most common types used in 2016 were massage (44%), chiropractic care (42%), yoga (27%), relaxation techniques (25%) and acupuncture (22%). According to the United States 2012 National Health Interview Survey (NHIS), 17.7% of American adults used a dietary supplement other than vitamins and minerals (3). A few surveys have sought to characterize the use of CAM in persons with diabetes. In a Canadian study of 502 people with diabetes, 44% were taking over-the-counter supplements with 31% taking alternative medications (4). A United States national survey reported 57% of those with diabetes using CAM in the previous year (5). The Medical Expenditure Panel Surveys (MEPS) showed that those with diabetes were 1.6 times more likely to use CAM than those without diabetes, with older age (≥65 years) and higher educational attainment (high school education or higher) independently associated with CAM use (6). An Australian study reported 25% of people with diabetes stated they had used CAM within the previous 5 years (7).

This chapter will review CAM, including natural health products (NHP) and others, such as yoga, acupuncture, tai chi and reflexology, that have been studied for the prevention and treatment of diabetes and its complications.

NHP for the Prevention and Treatment of Diabetes and Its Complications

In Canada, NHP are defined as vitamins and minerals, herbal remedies, homeopathic medicines, traditional medicines, such as traditional Chinese medicines, probiotics, and other products like amino acids and essential fatty acids (8). They are regulated under the Natural Health Products Regulations, which came into effect in 2004. In general, the current level of evidence for the efficacy and safety of NHP in people with diabetes is lower than that for pharmaceutical agents. Trials tend to be of shorter duration and involve smaller sample sizes. Concerns remain about standardization and purity of available compounds, including their contamination with regular medications and, in some cases, toxic substances (9–11). Various NHP have been studied to evaluate their impact on the development of both type 1 and type 2 diabetes, glycemic control in people with diabetes, and on the various complications of diabetes.

NHP for the Prevention and Treatment of Diabetes

A number of immune modulators have been studied in an attempt to prevent or arrest beta cell decline in type 1 diabetes, most with limited success. A few NHP have also been studied in this regard. A randomized controlled trial of people with new-onset type 1 diabetes assessed the effect of vitamin D supplementation on regulatory T (Treg) cells (12). After 12 months, Treg suppressive capacity was improved, although there was no significant reduction in C-peptide decline. Observational studies have suggested an inverse relationship between vitamin D levels and the development of type 2 diabetes (13), although randomized controlled trials are lacking (14). In the large, prospective cohort study, The Environmental Determinants of Diabetes in the Young (TEDDY), early probiotic supplementation may reduce the risk of islet autoimmunity in children at the highest genetic risk of type 1 diabetes (15).

A number of NHP have been evaluated to assess their effect on the progression from impaired glucose tolerance (IGT) to diabetes. Tianqi is a traditional Chinese medicine consisting of 10 different herbs. In a double-blind, placebo-controlled trial of 12 months duration, Tianqi was shown to reduce the progression from IGT to type 2 diabetes by 32% (16). A systematic review and meta-analysis of observational studies of omega-3 fatty acids or fish intake showed that an increased intake of alpha linoleic acid (ALA) and fatty fish reduced the risk of type 2 diabetes significantly with ALA, only in Asians (17). In a randomized controlled trial, the traditional Chinese medicine Shenzhu Tiaopi granule (SZTP) significantly reduced the conversion from IGT to type 2 diabetes to 8.52% from 15.28% with placebo, with a significantly higher number of people with IGT reverting to normal blood glucose levels as well (42.15% vs. 32.87% for placebo) (18).

In adults with type 2 diabetes, the following NHP have been shown to lower glycated hemoglobin (A1C) by at least 0.5% in randomized controlled trials lasting at least 3 months:

  • Ayurveda polyherbal formulation (19)
  • Citrullus colocynthis (20)
  • Coccinia cordifolia (21)
  • Eicosapentaenoic acid (22)
  • Ganoderma lucidum (23)
  • Ginger (Zingiber officinale) (24)
  • Gynostemma pentaphyllum (25)
  • Hintonia latiflora (26)
  • Lichen genus Cladonia BAFS “Yagel-Detox” (27)
  • Marine collagen peptides (28)
  • Nettle (Urtica dioica) (29)
  • Oral aloe vera (10)
  • Pterocarpus marsupium (vijayasar) (30)
  • Salacia reticulata (31)
  • Scoparia dulcis porridge (32)
  • Silymarin (33,34)
  • Soybean-derived pinitol extract (35)
  • Touchi soybean extract (36)
  • Traditional Chinese medicine herbs:
    • Berberine (37)
    • Fructus Mume (38)
    • Gegen Qinlian Decoction (GQD) (39)
    • Jianyutangkang (JYTK) with metformin (40)
    • Jinlida with metformin (41)
    • Sancaijiangtang (42)
    • Shen-Qi-Formula (SQF) with insulin (43)
    • Tang-Min-Ling-Wan (TM81) (44)
    • Xiaoke (contains glyburide) (11)
    • Zishentongluo (ZSTL) (45)
  • Trigonella foenum-graecum (fenugreek) (46,47)

These products are promising and merit consideration and further research, but, as they are mostly single, small trials or meta-analyses of such, it is premature to recommend their widespread use.

The following NHP either failed to lower A1C by 0.5% in trials lasting at least 3 months in adults with type 2 diabetes, or were studied in trials of shorter duration, nonrandomized or uncontrolled:

  • Agaricus blazei (48)
  • American ginseng (Panax quinquefolius L.) (49)
  • Antioxidants: (fruit/vegetable extract) (50), (pomegranate extract) (51)
  • Camellia sinensis (52)
  • Flaxseed oil (53)
  • French maritime pine bark (54)
  • Ginseng (55,56)
  • Juglans regia extract (57)
  • Liuwei Dihuang Pills (LDP) (58)
  • Momordica charantia (bitter melon or bitter gourd) (59,60)
  • Rosa canina L. (rose hip) (61)
  • Salvia officinalis (62)
  • Soy phytoestrogens (63)
  • Tinospora cordifolia (64)
  • Tinospora crispa (65)
  • Vitamin C (66–68)
  • Vitamin E (69–73)

The following NHP have demonstrated conflicting effects on A1C in trials lasting at least 3 months in adults with type 2 diabetes:

  • Cinnamon (74–79)
  • Coenzyme Q10 (80–83,85,86)
  • Ipomoea batatas (caiapo) (87,88)
  • L-carnitine (89–92)
  • Magnesium (93–99)
  • Omega 3 fatty acids (100,101)
  • Probiotics (102,103)
  • Zinc (104,105)

A few products, such as chromium, vitamin D and vanadium, have been the subjects of special interest in diabetes.

Chromium is an essential trace element involved in glucose and lipid metabolism. Early studies revealed that chromium deficiency could lead to IGT, which was reversible with chromium repletion. This led to a hypothesis that chromium supplementation, in those with both adequate and deficient chromium stores, could lead to improved glucose control in people with diabetes (106,107). Indeed, an analysis of the large NHANES database showed that, in those in the general population who reported consuming a chromium supplement, the odds of developing diabetes was 19% to 27% lower than those not taking a chromium supplement (108). However, randomized controlled studies of chromium supplementation have had conflicting results, with most showing no benefit on improving A1C (109–121), although some showed an improved fasting glucose level (120,121). Most were small studies, of short duration, and some not double-blinded. More recent meta-analyses have also reported conflicting results, with some concluding no benefit of chromium on reducing A1C, lipids or body weight in people with diabetes (122), and others reporting some benefit depending upon the dose and formulation consumed (84). The later meta-analysis reported marked heterogeneity and publication bias in the included studies.

Vitamin D has received much interest recently with purported benefits on cardiovascular disease (CVD), cancer and diabetes. Randomized controlled trials have not demonstrated a benefit of vitamin D supplementation on glycemic control in diabetes (123–138), further confirmed by meta-analyses (139,140).

Vanadium, a trace element that is commonly used to treat type 2 diabetes, has not been studied in randomized controlled trials evaluating glycemic control by A1C over a period of 3 months or longer.

NHP for the Treatment of the Co-Morbidities and Complications of Diabetes

A number of NHP have been evaluated for the various co-morbidities and complications of diabetes, including lipids and blood pressure (BP) in diabetes, as well as CVD, nephropathy, retinopathy and peripheral neuropathy. As with the studies of glycemic control, most had small sample sizes and meta-analyses had marked heterogeneity of included studies, making strong conclusions difficult.

Randomized controlled trials demonstrating a benefit on lipid parameters in diabetes include: Ayurvedic polyherbal formulation (19), Hintonia latiflora (26) and magnesium (99). In postmenopausal women with type 2 diabetes, vitamin D supplementation for 6 months reduced serum triglycerides (TG) without effect on other lipid parameters (141), while a meta-analysis with high heterogeneity showed benefit on lowering total cholesterol and TG (142). Other studies have failed to show significant benefit of vitamin D supplementation on lipids in people with diabetes (130,137,143). A meta-analysis of Berberine showed it to reduce TG and increase high-density lipoprotein cholesterol (HDL-C) more than traditional lipid-lowering drugs, with no difference on total or low-density lipoprotein cholesterol (LDL-C) (37). Berberine was also shown to reduce total and LDL-C and increase HDL-C combined with traditional lipid-lowering drugs compared with those drugs alone.

Randomized controlled trials demonstrating a benefit on systolic and/or diastolic BP include: magnesium (99), American ginseng (Panax quinquefolius L.) (49) and Purslane extract (Portulaca oleracea L.) (144). Berberine when combined with traditional BP medications can lower systolic BP by an additional 4.9 mmHg and diastolic BP by 2 mmHg, but not when compared with traditional antihypertensive medications alone (37). In 1 meta-analysis, vitamin D was shown to reduce BP by a statistically significant, but not clinically meaningful amount (145).

Ethylene diamine tetra-acetic (EDTA) acid chelation therapy has been postulated to have a number of cardiovascular (CV) benefits. A large randomized controlled trial (Trial to Assess Chelation Therapy—TACT) showed a modest benefit of an 18% risk reduction for a composite of CV complications in people with a recent myocardial infarct (146). A pre-specified subanalysis of people with diabetes showed a more robust 39% to 41% risk reduction in the primary endpoint out to 5-years follow up (147).

The traditional Chinese medicine product, The Compound Danshen Dripping Pill (CDDP), consisting of 3 herbal preparations, was evaluated in a randomized controlled trial of 24 weeks duration, for its effect on the progression of diabetic retinopathy (148). Using a nonstandardized method of grading fluorescence fundal angiography, higher doses of CDDP were found to delay the progression of diabetic retinopathy.

A number of NHP have been reported to improve diabetic nephropathy. However, there is variation in the definition of diabetic nephropathy in the various studies, with many assessing urinary albumin excretion (UAE) and/or 24-hour urine protein excretion without a confirmatory diagnosis. Many are of short duration, some without reporting an assessment of renal function or its progression, or with conflicting results on the various measures. Some products showing a reduction in UAE in people with diabetes include: the traditional Chinese medicines Yiqi Huayu, Yiqi Yangyin (149), Qidan Dihuang Grain (150), and Jiangzhuo (SKC-YJ) (151), Huangshukuihua (Flos Abelmoschi Manihot) (152,153), Pueraria lobata (gegen, puerarin) (154), Tangshen Formula (155), Zishentongluo (ZSTL) (45), vitamin D (156), and vitamin D analogue paricalcitol in type 1 diabetes (157).

A number of NHP have been reported to improve diabetic peripheral neuropathy, as assessed by pain scores and/or nerve conduction studies (NCS). Topical Citrullus colocynthis (bitter apple) extract oil was studied in a small randomized controlled trial in people with painful diabetic polyneuropathy (158). After 3 months, there was a significantly greater decrease in mean pain score and improvement in nerve conduction velocities compared with placebo. A meta-analysis of puerarin in diabetic peripheral neuropathy reported benefits in pain scores and NCS (159). In a small randomized controlled trial, the traditional Chinese medicine MHGWT showed reduced pain scores compared with placebo after 12 weeks of treatment (160).

A number of the above and other NHP have been evaluated for their effects on various pre-clinical parameters, biomarkers and surrogate clinical markers involved in the pathogenesis of diabetes and its complications. A discussion of these papers is beyond the scope of this chapter.

Adverse Effects

It is important to consider potential harm from the use of NHP. A number of studies of NHP report adverse events, such as gastrointestinal (Fenugreek, Berberine, TM81, bitter melon, oral aloe vera) and dizziness (JYTK). In 1 trial of Tinospora crispa, hepatotoxicity was seen in 2 participants (65). Large doses of Citrullus colocyn can induce diarrhea, but no side effects were reported in the lower doses used in 1 trial (20). Momordica charantia, an NHP commonly used for glycemic control, is an abortifacient (161). Most clinical trials have evaluated small sample sizes over relatively short periods of time and, thus, may not identify all potential side effects or risks.

Some NHP contain pharmaceutical ingredients and/or properties. The Xiaoke Pill contains glibenclamide (glyburide) (11). Nettle has insulin secretagogue, peroxisome proliferator-activated receptor (PPAR) and alpha-glucosidase activities. Only NHPs that are properly labelled with a valid natural product number (NPN) should be used to avoid adulteration with unlabelled pharmaceuticals or other contaminants.

Drug-herb interactions may also occur. The most well described is Hypericum perforatum (St. John's wort), which can affect the metabolism of many drugs, including statins, by inducing cytochrome P450 3A4 (CYP3A4). Some studies have reported poorer glycemic control in people using glucosamine sulfate for osteoarthritis, but a systematic review concluded that the evidence does not support this concern (162).

Other Complementary and Alternative Approaches for the Prevention and Treatment of Diabetes and Its Complications

A number of complementary and alternative approaches have been studied to some degree for diabetes and its complications, others have not. Included here are studies of yoga, traditional Chinese medicine and reflexology. Other modalities of CAM, such as chiropractic or osteopathic manipulation, homeopathy, shiatsu, registered massage therapy or craniosacral therapy do not have studies specific to diabetes.

Yoga

The Sanskrit definition of yoga means union or connection. Yoga is a Hindu spiritual discipline. There are many types of yoga, each with its own techniques and methods to awaken greater awareness and connection to self and life. Most practices of yoga include a series of physical postures, breathing and meditation for health, relaxation and overall well-being. Yoga or yoga therapy is often included in a holistic practitioner's (chiropractor, naturopath, osteopath, shiatsu therapist) plan of management for stress reduction and physical strengthening.

Studies of yoga in the management of people with type 2 diabetes show some benefit on glycemic control, lipids and BP, although published studies are generally of short duration with small numbers. In a systematic review and meta-analysis, yoga was found to have positive effects on reducing A1C, as well as fasting and postprandial glucose values (163). There was high heterogeneity among the studies included in the analysis. Other systematic reviews and meta-analyses showed similar improvements in glycemic parameters, as well as improvements in the lipid profile and BP, with similar limitations in the individual studies included (164,165) (see Physical Activity and Diabetes chapter, p. S54). In a meta-analysis of smaller studies looking at comparing the effectiveness of the leisure activities yoga, walking and tai chi on glycemic control in people with type 2 diabetes, yoga with regular frequency (3 times a week) was shown to be more effective than tai chi or walking in lowering A1C levels (166).

Traditional Chinese Medicine

Traditional Chinese medicine (TCM) encompasses a holistic system that includes the combination of herbal medicines, acupuncture, tui na (rigorous massage), dietary therapy, qi gong and tai chi (mind/body techniques combining breathing, movement and mental focus). TCM works within a different paradigm than Western Medicine and, as such, can be difficult to study by Western research techniques. Treatments are complex and focused on individual imbalances detected by pulse and tongue diagnosis rather than specific diseases. Most research on the effectiveness of TCM for people with diabetes is based on specific techniques or Chinese herbal remedies as reviewed above.

Acupuncture is a branch of TCM involving the stimulation of specific points along energy meridians throughout the body to either sedate or tonify the flow of energy. There are various techniques of acupuncture, such as electro and laser acupuncture, and different systems of acupuncture, including scalp and auricular acupuncture. The system and technique most commonly referred to and most often studied refers to the technique of penetrating the skin at specific acupuncture points with thin solid metal needles that are manipulated by the hands.

Acupuncture has not been shown to improve A1C in people with diabetes, with 1 small randomized controlled trial showing it to be no different than placebo on FPG and oral glucose tolerance testing (OGTT) (167). A meta-analysis of acupuncture for diabetic gastroparesis concluded that acupuncture improved some dyspeptic symptoms, such as nausea, vomiting, loss of appetite and stomach fullness, with no improvement in solid gastric emptying (168). A systematic review of randomized controlled trials of manual acupuncture for the treatment of diabetic peripheral neuropathy reported that manual acupuncture had a better effect on global symptom improvement compared with vitamin B12 or no treatment, and that the combination of manual acupuncture and vitamin B12 had a better effect compared with vitamin B12 alone. However, the authors could not draw clinically relevant conclusions because of high risks of bias in the studies included (169).

Tai chi is an ancient mind and body practice involving gentle, slow, continuous body movements with mental focus, breathing and relaxation. Although there may be some benefit in quality of life, there is little evidence for benefit of tai chi on glycemic control in diabetes (170,171).

Manual Therapies

There is a growing number of people with diabetes who seek care for musculoskeletal complaints and overall lifestyle management from natural and/or complementary medicine practitioners. Manual therapies, including chiropractic, physiotherapy, shiatsu, registered massage therapy and craniosacral therapy have no randomized controlled trial data in people with diabetes. A few small studies on tactile massage, a superficial gentle form of massage, have failed to demonstrate a significant beneficial effect on A1C (172–174). Reflexology is a system of massage based on the theory that reflex points on the feet, hands and head are linked to other internal parts of the body. In a small, open-label, randomized controlled trial in people with diabetic peripheral neuropathy, foot reflexology was shown to reduce A1C and FPG, and improve pain scores and nerve conduction velocity (175).

Recommendations

  1. Health-care providers should ask about the use of complementary and alternative medicine in people with diabetes [Grade D, Consensus].

  2. There is insufficient evidence to make a recommendation regarding efficacy and safety of complementary or alternative medicine for individuals with diabetes [Grade D, Consensus].

Abbreviations:

A1C, glycated hemoglobin; ALA, alpha linoleic acid; BP, blood pressure; CAM, complementary or alternative medicine; CV, cardiovascular; CVD, cardiovascular disease; FPG, fasting plasma glucose; HDL-C, high-density lipoprotein cholesterol; IGT, impaired glucose tolerance; LDL-C, low-density lipoprotein cholesterol; MI, myocardial infarct; NCS, nerve conduction studies; NHP, natural health product; NPN, natural product number; OGTT, oral glucose tolerance test; TCM, traditional Chinese medicine; TG, triglycerides, UAE, urinary albumin excretion.

Other Relevant Guidelines

  • Physical Activity and Diabetes, p. S54

Literature Review Flow Diagram for Chapter 22: Complementary and Alternative Medicine for Diabetes

*Excluded based on: population, intervention/exposure, comparator/control or study design.

From: Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6(6): e1000097. doi:10.1371/journal.pmed1000097 (176).

For more information, visit www.prisma-statement.org.

Author Disclosures

Dr. Grossman reports grants and personal fees from Novo Nordisk, Janssen, and Eli Lilly; grants from Merck, Takeda, Sanofi, AstraZeneca, and Lexicon, outside the submitted work; and previous employee (now retired) of Eli Lilly Canada. No other authors have anything to disclose.

References

  1. National Center for Complementary and Integrative HealthComplementary, alternative, or integrative health: What's in a name?2016National Institue of Health (NIH), U.S. Department of Health and Human ServicesBethesdahttps://nccih.nih.gov/health/integrative-health
  2. N.EsmailComplementary and alternative medicine: Use and public attitudes 1997, 2006, and 20162017Fraser InstitueVancouverhttps://www.fraserinstitute.org/sites/default/files/complementary-and-alternative-medicine-2017.pdf
  3. T.C.ClarkeL.I.BlackB.J.StussmanTrends in the use of complementary health approaches among adults: United States, 2002–2012Natl Health Stat Report2015116
  4. E.A.RyanM.E.PickC.MarceauUse of alternative medicines in diabetes mellitusDiabet Med182001242245
  5. G.Y.YehD.M.EisenbergR.B.DavisUse of complementary and alternative medicine among persons with diabetes mellitus: Results of a national surveyAm J Public Health92200216481652
  6. L.E.EgedeYeX.ZhengD.The prevalence and pattern of complementary and alternative medicine use in individuals with diabetesDiabetes Care252002324329
  7. TanA.C.J.C.MakComplementary and Alternative Medicine in Diabetes (CALMIND)—a prospective studyJ Complement Integr Med1220159599
  8. Non-prescription Health Products Directorate (NNHPD)What are natural health products2004Health CanadaOttawahttp://www.hc-sc.gc.ca/dhp-mps/prodnatur/index-eng.php
  9. R.B.SaperS.N.KalesJ.PaquinHeavy metal content of ayurvedic herbal medicine productsJAMA292200428682873
  10. W.R.DickE.A.FletcherS.A.ShahReduction of fasting blood glucose and hemoglobin A1c using oral aloe vera: A meta-analysisJ Altern Complement Med222016450457
  11. JiL.TongX.WangH.Efficacy and safety of traditional chinese medicine for diabetes: A double-blind, randomised, controlled trialPLoS ONE82013e56703
  12. G.TreiberB.PrietlE.Fröhlich-ReitererCholecalciferol supplementation improves suppressive capacity of regulatory T-cells in young patients with new-onset type 1 diabetes mellitus—a randomized clinical trialClin Immunol1612015217224
  13. H.KhanS.KunutsorO.H.FrancoVitamin D, type 2 diabetes and other metabolic outcomes: A systematic review and meta-analysis of prospective studiesProc Nutr Soc7220138997
  14. S.LimM.J.KimS.H.ChoiAssociation of vitamin D deficiency with incidence of type 2 diabetes in high-risk Asian subjectsAm J Clin Nutr972013524530
  15. U.UusitaloLiuX.YangJ.Association of early exposure of probiotics and islet autoimmunity in the TEDDY studyJAMA Pediatr17020162028
  16. LianF.LiG.ChenX.Chinese herbal medicine Tianqi reduces progression from impaired glucose tolerance to diabetes: A double-blind, randomized, placebo-controlled, multicenter trialJ Clin Endocrinol Metab9922014648655
  17. A.MuleyP.MuleyM.ShahALA, fatty fish or marine n-3 fatty acids for preventing DM?: A systematic review and meta-analysisCurr Diabetes Rev102014158165
  18. FangZ.ZhaoJ.ShiG.Shenzhu Tiaopi granule combined with lifestyle intervention therapy for impaired glucose tolerance: A randomized controlled trialComplement Ther Med222014842850
  19. H.AwasthiR.NathK.UsmanEffects of a standardized Ayurvedic formulation on diabetes control in newly diagnosed type-2 diabetics; a randomized active controlled clinical studyComplement Ther Med232015555561
  20. H.F.HuseiniF.DarvishzadehR.HeshmatThe clinical investigation of Citrullus colocynthis (L.) schrad fruit in treatment of type II diabetic patients: A randomized, double blind, placebo-controlled clinical trialPhytother Res23200911861189
  21. R.KuriyanR.RajendranG.BantwalEffect of supplementation of Coccinia cordifolia extract on newly detected diabetic patientsDiabetes Care312008216220
  22. S.SarboloukiM.H.JavanbakhtH.DerakhshanianEicosapentaenoic acid improves insulin sensitivity and blood sugar in overweight type 2 diabetes mellitus patients: A double-blind randomised clinical trialSingapore Med J542013387390
  23. GaoY.J.LanDaiX.A phase I/II study of Ling Zhi mushroom Ganoderma lucidum (W.Curt.:Fr.) Lloyd (Aphyllophoromycetidae) extract in patients with type 2 diabetesInt J Med Mushrooms620043339
  24. F.ShidfarA.RajabT.RahidehThe effect of ginger (Zingiber officinale) on glycemic markers in patients with type 2 diabetesJ Complement Integr Med122015165170
  25. V.T.HuyenD.V.PhanP.ThangAntidiabetic effect of Gynostemma pentaphyllum tea in randomly assigned type 2 diabetic patientsHorm Metab Res422010353357
  26. M.KorecovaM.HladikovaTreatment of mild and moderate type-2 diabetes: Open prospective trial with hintonia latiflora extractEur J Med Res19201416
  27. B.M.KershengoltsL.A.SydykovaV.V.SharoykoLichens' B-Oligosaccharides in the correction of metabolic disorders in type 2 diabetes MellitusWiad Lek682015480482
  28. ZhuC.F.LiG.Z.PengH.B.Treatment with marine collagen peptides modulates glucose and lipid metabolism in Chinese patients with type 2 diabetes mellitusAppl Physiol Nutr Metab352010797804
  29. S.KianbakhtF.Khalighi-SigaroodiF.H.DabaghianImproved glycemic control in patients with advanced type 2 diabetes mellitus taking Urtica dioica leaf extract: A randomized double-blind placebo-controlled clinical trialClin Lab59201310711076
  30. R.S.HariharanS.VankataramanP.SunithaEfficacy of vijayasar (Pterocarpus marsupium) in the treatment of newly diagnosed patients with type 2 diabetes mellitus: A flexible dose double-blind multicenter randomized controlled trialDiabetol Croat3420051320http://www.idb.hr/diabetologia/05no1-2.pdf
  31. M.H.JayawardenaN.M.de AlwisV.HettigodaA double blind randomised placebo controlled cross over study of a herbal preparation containing Salacia reticulata in the treatment of type 2 diabetesJ Ethnopharmacol972005215218
  32. S.P.SenadheeraS.EkanayakeC.WanigatungeAnti-hyperglycaemic effects of herbal porridge made of Scoparia dulcis leaf extract in diabetics—a randomized crossover clinical trialBMC Complement Altern Med152015410
  33. S.A.HussainSilymarin as an adjunct to glibenclamide therapy improves long-term and postprandial glycemic control and body mass index in type 2 diabetesJ Med Food102007543547
  34. H.F.HuseiniB.LarijaniR.HeshmatThe efficacy of Silybum marianum (L.) Gaertn. (silymarin) in the treatment of type II diabetes: A randomized, double-blind, placebo-controlled, clinical trialPhytother Res20200610361039
  35. KangM.J.J.I.KimS.Y.YoonPinitol from soybeans reduces postprandial blood glucose in patients with type 2 diabetes mellitusJ Med Food92006182186
  36. H.FujitaT.YamagamiK.OhshimaLong-term ingestion of a fermented soybean-derived Touchi-extract with alpha-glucosidase inhibitory activity is safe and effective in humans with borderline and mild type-2 diabetesJ Nutr131200121052108
  37. J.LanZhaoY.DongF.Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertensionJ Ethnopharmacol16120156981
  38. TuX.XieC.WangF.Fructus mume formula in the treatment of type 2 diabetes mellitus: A randomized controlled pilot trialEvid Based Complement Alternat Med20132013787459
  39. XuJ.LianF.ZhaoL.Structural modulation of gut microbiota during alleviation of type 2 diabetes with a Chinese herbal formulaISME J92015552562
  40. HuY.ZhouX.GuoD.H.Effect of JYTK on antioxidant status and inflammation in patients with type 2 diabetes: A randomized double-blind clinical trialInt J Endocrinol Metab142016e34400
  41. LianF.TianJ.ChenX.The efficacy and safety of chinese herbal medicine jinlida as add-on medication in type 2 diabetes patients ineffectively managed by metformin monotherapy: A double-blind, randomized, placebo-controlled, multicenter trialPLoS ONE102015e0130550
  42. QiangG.C.WenzhaiHuanZ.Effect of Sancaijiangtang on plasma nitric oxide and endothelin-1 levels in patients with type 2 diabetes mellitus and vascular dementia: A single-blind randomized controlled trialJ Tradit Chin Med352015375380
  43. ZhangX.LiuY.XiongD.Insulin combined with Chinese medicine improves glycemic outcome through multiple pathways in patients with type 2 diabetes mellitusJ Diabetes Investig62015708715
  44. TongX.L.WuS.T.LianF.M.The safety and effectiveness of TM81, a Chinese herbal medicine, in the treatment of type 2 diabetes: A randomized double-blind placebo-controlled trialDiabetes Obes Metab152013448454
  45. MaJ.XuL.DongJ.Effects of zishentongluo in patients with early-stage diabetic nephropathyAm J Chin Med412013333340
  46. LuF.R.ShenL.QinY.Clinical observation on trigonella foenum-graecum L. total saponins in combination with sulfonylureas in the treatment of type 2 diabetes mellitusChin J Integr Med1420085660
  47. N.NeelakantanM.NarayananR.J.de SouzaEffect of fenugreek (Trigonella foenum-graecum L.) intake on glycemia: A meta-analysis of clinical trialsNutr J1320147
  48. C.H.HsuLiaoY.L.LinS.C.The mushroom Agaricus Blazei Murill in combination with metformin and gliclazide improves insulin resistance in type 2 diabetes: A randomized, double-blinded, and placebo-controlled clinical trialJ Altern Complement Med13200797102
  49. I.MucaloE.JovanovskiD.RahelićEffect of American ginseng (Panax quinquefolius L.) on arterial stiffness in subjects with type-2 diabetes and concomitant hypertensionJ Ethnopharmacol1502013148153
  50. E.RytterB.VessbyR.AsgardSupplementation with a combination of antioxidants does not affect glycaemic control, oxidative stress or inflammation in type 2 diabetes subjectsFree Radic Res44201014451453
  51. A.K.FenerciogluT.SalerE.GencThe effects of polyphenol-containing antioxidants on oxidative stress and lipid peroxidation in type 2 diabetes mellitus without complicationsJ Endocrinol Invest332010118124
  52. T.MackenzieL.LearyW.B.BrooksThe effect of an extract of green and black tea on glucose control in adults with type 2 diabetes mellitus: Double-blind randomized studyMetabolism56200713401344
  53. D.E.BarreK.A.Mizier-BarreO.GrisctiHigh dose flaxseed oil supplementation may affect fasting blood serum glucose management in human type 2 diabeticsJ Oleo Sci572008269273
  54. LiuX.WeiJ.TanF.Antidiabetic effect of Pycnogenol French maritime pine bark extract in patients with diabetes type IILife Sci75200425052513
  55. GuiQ.F.XuZ.R.XuK.Y.The efficacy of ginseng-related therapies in type 2 diabetes mellitus: An updated systematic review and meta-analysisMedicine (Baltimore)952016e2584
  56. E.ShishtarJ.L.SievenpiperV.DjedovicThe effect of ginseng (the genus panax) on glycemic control: A systematic review and meta-analysis of randomized controlled clinical trialsPLoS ONE92014e107391
  57. S.HosseiniL.JamshidiS.MehrzadiEffects of Juglans regia L. leaf extract on hyperglycemia and lipid profiles in type two diabetic patients: A randomized double-blind, placebo-controlled clinical trialJ Ethnopharmacol1522014451456
  58. PuR.GengX.N.YuF.Liuwei dihuang pills enhance the effect of Western medicine in treating type 2 diabetes: A meta-analysis of randomized controlled trialsChin J Integr Med192013783791
  59. A.M.DansM.V.VillarruzC.A.JimenoThe effect of Momordica charantia capsule preparation on glycemic control in type 2 diabetes mellitus needs further studiesJ Clin Epidemiol602007554559
  60. YinR.V.N.C.LeeH.HirparaThe effect of bitter melon (Mormordica charantia) in patients with diabetes mellitus: A systematic review and meta-analysisNutr Diabetes42014e145
  61. F.Hashem DabaghianM.AbdollahifardF.Khalighi SigarudiEffects of Rosa canina L. fruit on glycemia and lipid profile in type 2 diabetic patients: A randomized, double-blind, placebo-controlled clinical trialJ Med Plants14201595104
  62. S.BehradmaneshF.DereesM.Rafieian-KopaeiEffect of salvia officinalis on diabetic patientsJ Renal Inj Prev220135154
  63. V.JayagopalP.AlbertazziE.S.KilpatrickBeneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetesDiabetes Care25200217091714
  64. V.KumarF.MahdiR.SinghA clinical trial to assess the antidiabetic, antidyslipidemic and antioxidant activities of Tinospora cordifolia in management of type - 2 diabetes mellitusInt J Pharm Sci Res72016757764http://ijpsr.com/bft-article/a-clinical-trial-to-assess-the-antidiabetic-antidyslipidemic-and-antioxidant-activities-of-tinospora-cordifolia-in-management-of-type-2-diabetes-mellitus/?view=fulltext
  65. C.SangsuwanS.UdompanthurakS.VannasaengRandomized controlled trial of Tinospora crispa for additional therapy in patients with type 2 diabetes mellitusJ Med Assoc Thai872004543546
  66. ChenH.R.J.KarneG.HallHigh-dose oral vitamin C partially replenishes vitamin C levels in patients with type 2 diabetes and low vitamin C levels but does not improve endothelial dysfunction or insulin resistanceAm J Physiol Heart Circ Physiol2902006H137H145
  67. J.K.BhattS.ThomasM.J.NanjanEffect of oral supplementation of vitamin C on glycemic control and lipid profile in patients with type 2 diabetes mellitusInt J Pharm Pharm Sci42012524527
  68. O.Tabatabaei-MalazyS.NikfarB.LarijaniInfluence of ascorbic acid supplementation on type 2 diabetes mellitus in observational and randomized controlled trials; a systematic review with meta-analysisJ Pharm Pharm Sci172014554582
  69. E.LonnS.YusufB.HoogwerfEffects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: Results of the HOPE study and MICRO-HOPE substudyDiabetes Care25200219191927
  70. M.BoshtamM.RafieiI.D.GolshadiLong term effects of oral vitamin E supplement in type II diabetic patientsInt J Vitam Nutr Res752005341346
  71. N.SuksomboonN.PoolsupS.SinprasertEffects of vitamin E supplementation on glycaemic control in type 2 diabetes: Systematic review of randomized controlled trialsJ Clin Pharm Ther3620115363
  72. A.UdupaP.NaharS.ShahA comparative study of effects of omega-3 fatty acids, alpha lipoic acid and vitamin e in type 2 diabetes mellitusAnn Med Health Sci Res32013442446
  73. XuR.ZhangS.TaoA.Influence of vitamin E supplementation on glycaemic control: A meta-analysis of randomised controlled trialsPLoS ONE92014e95008
  74. B.MangM.WoltersB.SchmittEffects of a cinnamon extract on plasma glucose, HbA, and serum lipids in diabetes mellitus type 2Eur J Clin Invest362006340344
  75. S.M.BlevinsM.J.LeyvaJ.BrownEffect of cinnamon on glucose and lipid levels in non insulin-dependent type 2 diabetesDiabetes Care30200722362237
  76. P.CrawfordEffectiveness of cinnamon for lowering hemoglobin A1C in patients with type 2 diabetes: A randomized, controlled trialJ Am Board Fam Med222009507512
  77. R.AkilenA.TsiamiD.DevendraGlycated haemoglobin and blood pressure-lowering effect of cinnamon in multi-ethnic type 2 diabetic patients in the UK: A randomized, placebo-controlled, double-blind clinical trialDiabet Med27201011591167
  78. S.SuppapitipornN.KanpaksiS.SuppapitipornThe effect of cinnamon cassia powder in type 2 diabetes mellitusJ Med Assoc Thai89Suppl. 32006S200S205
  79. R.W.AllenE.SchwartzmanW.L.BakerCinnamon use in type 2 diabetes: An updated systematic review and meta-analysisAnn Fam Med112013452459
  80. J.G.ErikssonT.J.ForsenS.A.MortensenThe effect of coenzyme Q10 administration on metabolic control in patients with type 2 diabetes mellitusBiofactors91999315318
  81. R.Kolahdouz MohammadiM.J.Hosseinzadeh-AttarM.R.EshraghianThe effect of coenzyme Q10 supplementation on metabolic status of type 2 diabetic patientsMinerva Gastroenterol Dietol592013231236
  82. N.SuksomboonN.PoolsupN.JuanakEffects of coenzyme Q10 supplementation on metabolic profile in diabetes: A systematic review and meta-analysisJ Clin Pharm Ther402015413418
  83. H.ZahediS.EghtesadiS.SeifiradEffects of CoQ10 supplementation on lipid profiles and glycemic control in patients with type 2 diabetes: A randomized, double blind, placebo-controlled trialJ Diabetes Metab Disord13201481
  84. N.SuksomboonN.PoolsupA.YuwanakornSystematic review and meta-analysis of the efficacy and safety of chromium supplementation in diabetesJ Clin Pharm Ther392014292306
  85. M.Akbari FakhrabadiA.Zeinali GhotromH.Mozaffari-KhosraviEffect of coenzyme Q10 on oxidative stress, glycemic control and inflammation in diabetic neuropathy: A double blind randomized clinical trialInt J Vitam Nutr Res842014252260
  86. M.MoradiF.HaghighatdoostA.FeiziEffect of coenzyme Q10 supplementation on diabetes biomarkers: A systematic review and meta-analysis of randomized controlled clinical trialsArch Iran Med192016588596
  87. B.LudvikB.NeufferG.PaciniEfficacy of Ipomoea batatas (Caiapo) on diabetes control in type 2 diabetic subjects treated with dietDiabetes Care272004436440
  88. B.LudvikM.HanefeldG.PaciniImproved metabolic control by Ipomoea batatas (Caiapo) is associated with increased adiponectin and decreased fibrinogen levels in type 2 diabetic subjectsDiabetes Obes Metab102008586592
  89. G.DerosaA.F.CiceroA.GaddiThe effect of L-carnitine on plasma lipoprotein(a) levels in hypercholesterolemic patients with type 2 diabetes mellitusClin Ther25200314291439
  90. A.R.RahbarR.ShakerhosseiniN.SaadatEffect of L-carnitine on plasma glycemic and lipidemic profile in patients with type II diabetes mellitusEur J Clin Nutr592005592596
  91. G.DerosaP.MaffioliI.FerrariOrlistat and L-carnitine compared to orlistat alone on insulin resistance in obese diabetic patientsEndocr J572010777786
  92. G.DerosaP.MaffioliS.A.SalvadeoSibutramine and L-carnitine compared to sibutramine alone on insulin resistance in diabetic patientsIntern Med49201017171725
  93. M.Rodriguez-MoranF.Guerrero-RomeroOral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: A randomized double-blind controlled trialDiabetes Care26200311471152
  94. H.W.de ValkR.VerkaaikH.J.van RijnOral magnesium supplementation in insulin-requiring type 2 diabetic patientsDiabet Med151998503507
  95. N.L.EiblH.P.KoppH.R.NowakHypomagnesemia in type II diabetes: Effect of a 3-month replacement therapyDiabetes Care181995188192
  96. J.ErikssonA.KohvakkaMagnesium and ascorbic acid supplementation in diabetes mellitusAnn Nutr Metab391995217223
  97. SongY.HeK.E.B.LevitanEffects of oral magnesium supplementation on glycaemic control in Type 2 diabetes: A meta-analysis of randomized double-blind controlled trialsDiabet Med23200610501056
  98. A.Navarrete-CortesJ.L.Ble-CastilloF.Guerrero-RomeroNo effect of magnesium supplementation on metabolic control and insulin sensitivity in type 2 diabetic patients with normomagnesemiaMagnes Res2720144856
  99. M.SolatiE.OuspidS.HosseiniOral magnesium supplementation in type II diabetic patientsMed J Islam Repub Iran28201467
  100. J.VelebaJ.KopeckyJrP.JanovskaCombined intervention with pioglitazone and n-3 fatty acids in metformin-treated type 2 diabetic patients: Improvement of lipid metabolismNutr Metab (Lond)1220155267
  101. ChenC.YuX.ShaoS.Effects of omega-3 fatty acid supplementation on glucose control and lipid levels in type 2 diabetes: A meta-analysisPLoS ONE102015e0139565
  102. ZhangQ.WuY.FeiX.Effect of probiotics on glucose metabolism in patients with type 2 diabetes mellitus: A meta-analysis of randomized controlled trialsMedicina (Kaunas)5220162834
  103. E.RazmpooshM.JavadiH.S.EjtahedProbiotics as beneficial agents in the management of diabetes mellitus: A systematic reviewDiabetes Metab Res Rev322016143168
  104. J.CapdorM.FosterP.PetoczZinc and glycemic control: A meta-analysis of randomised placebo controlled supplementation trials in humansJ Trace Elem Med Biol272013137142
  105. R.JayawardenaP.RanasingheP.GalappatthyEffects of zinc supplementation on diabetes mellitus: A systematic review and meta-analysisDiabetol Metab Syndr4201213
  106. G.W.LandmanH.J.BiloS.T.HouwelingChromium does not belong in the diabetes treatment arsenal: Current evidence and future perspectivesWorld J Diabetes52014160164
  107. S.LewickiR.ZdanowskiM.KrzyzowskaThe role of Chromium III in the organism and its possible use in diabetes and obesity treatmentAnn Agric Environ Med212014331335
  108. D.J.McIverA.M.GrizalesJ.S.BrownsteinRisk of type 2 diabetes Is lower in US adults taking chromium-containing supplementsJ Nutr145201526752682
  109. M.D.AlthuisN.E.JordanE.A.LudingtonGlucose and insulin responses to dietary chromium supplements: A meta-analysisAm J Clin Nutr762002148155
  110. J.MartinWangZ.Q.ZhangX.H.Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetesDiabetes Care29200618261832
  111. N.KleefstraS.T.HouwelingF.G.JansmanChromium treatment has no effect in patients with poorly controlled, insulin-treated type 2 diabetes in an obese Western population: A randomized, double-blind, placebo-controlled trialDiabetes Care292006521525
  112. D.GhoshB.BhattacharyaB.MukherjeeRole of chromium supplementation in Indians with type 2 diabetes mellitusJ Nutr Biochem132002690697
  113. R.A.AndersonA.M.RousselN.ZouariPotential antioxidant effects of zinc and chromium supplementation in people with type 2 diabetes mellitusJ Am Coll Nutr202001212218
  114. R.A.AndersonChengN.N.A.BrydenElevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetesDiabetes46199717861791
  115. N.KleefstraS.T.HouwelingS.J.BakkerChromium treatment has no effect in patients with type 2 diabetes in a Western population: A randomized, double-blind, placebo-controlled trialDiabetes Care30200710921096
  116. E.M.BalkA.TatsioniA.H.LichtensteinEffect of chromium supplementation on glucose metabolism and lipids: A systematic review of randomized controlled trialsDiabetes Care30200721542163
  117. C.A.AlbarracinB.C.FuquaJ.L.EvansChromium picolinate and biotin combination improves glucose metabolism in treated, uncontrolled overweight to obese patients with type 2 diabetesDiabetes Metab Res Rev2420084151
  118. C.AlbarracinB.FuquaJ.GeohasCombination of chromium and biotin improves coronary risk factors in hypercholesterolemic type 2 diabetes mellitus: A placebo-controlled, double-blind randomized clinical trialJ Cardiometab Syndr220079197
  119. LaiM.H.Antioxidant effects and insulin resistance improvement of chromium combined with vitamin C and e supplementation for type 2 diabetes mellitusJ Clin Biochem Nutr432008191198
  120. M.AbdollahiA.FarshchiS.NikfarEffect of chromium on glucose and lipid profiles in patients with type 2 diabetes; a meta-analysis review of randomized trialsJ Pharm Pharm Sci16201399114
  121. A.N.PaivaJ.G.LimaA.C.MedeirosBeneficial effects of oral chromium picolinate supplementation on glycemic control in patients with type 2 diabetes: A randomized clinical studyJ Trace Elem Med Biol3220156672
  122. YinR.V.O.J.PhungEffect of chromium supplementation on glycated hemoglobin and fasting plasma glucose in patients with diabetes mellitusNutr J14201514
  123. M.D.WithamF.J.DoveM.DryburghThe effect of different doses of vitamin D(3) on markers of vascular health in patients with type 2 diabetes: A randomised controlled trialDiabetologia53201021122119
  124. P.PatelL.PoretskyLiaoE.Lack of effect of subtherapeutic vitamin D treatment on glycemic and lipid parameters in type 2 diabetes: A pilot prospective randomized trialJ Diabetes220103640
  125. R.JordeY.FigenschauSupplementation with cholecalciferol does not improve glycaemic control in diabetic subjects with normal serum 25-hydroxyvitamin D levelsEur J Nutr482009349354
  126. H.NasriS.BehradmaneshA.R.MaghsoudiEfficacy of supplementary vitamin D on improvement of glycemic parameters in patients with type 2 diabetes mellitus; a randomized double blind clinical trialJ Renal Inj Prev320143134
  127. N.Nigil HaroonA.AntonJ.JohnEffect of vitamin D supplementation on glycemic control in patients with type 2 diabetes: A systematic review of interventional studiesJ Diabetes Metab Disord1420153
  128. N.G.ForouhiR.K.MenonS.J.SharpEffects of vitamin D2 or D3 supplementation on glycaemic control and cardiometabolic risk among people at risk of type 2 diabetes: Results of a randomized double-blind placebo-controlled trialDiabetes Obes Metab182016392400
  129. S.GhavamzadehM.MobasseriR.MahdaviThe effect of vitamin D supplementation on adiposity, blood glycated hemoglobin, serum leptin and tumor necrosis factor-alpha in type 2 diabetic patientsInt J Prev Med5201410911098
  130. Y.H.Krul-PoelS.WestraE.ten BoekelEffect of vitamin D supplementation on glycemic control in patients with type 2 diabetes (SUNNY trial): A randomized placebo-controlled trialDiabetes Care38201514201426
  131. B.U.NwosuL.MarandaThe effects of vitamin D supplementation on hepatic dysfunction, vitamin D status, and glycemic control in children and adolescents with vitamin D deficiency and either type 1 or type 2 diabetes mellitusPLoS ONE92014e99646
  132. S.ElkassabyL.C.HarrisonN.MazzitelliA randomised controlled trial of high dose vitamin D in recent-onset type 2 diabetesDiabetes Res Clin Pract1062014576582
  133. F.StrobelJ.ReuschM.Penna-MartinezEffect of a randomised controlled vitamin D trial on insulin resistance and glucose metabolism in patients with type 2 diabetes mellitusHorm Metab Res4620145458
  134. S.JehleA.LardiB.FelixEffect of large doses of parenteral vitamin D on glycaemic control and calcium/phosphate metabolism in patients with stable type 2 diabetes mellitus: A randomised, placebo-controlled, prospective pilot studySwiss Med Wkly1442014w13942
  135. O.H.RyuS.LeeYuJ.A prospective randomized controlled trial of the effects of vitamin D supplementation on long-term glycemic control in type 2 diabetes mellitus of KoreaEndocr J612014167176
  136. M.E.Al-SofianiA.JammahM.RaczEffect of vitamin D supplementation on glucose control and inflammatory response in type II diabetes: A double blind, randomized clinical trialInt J Endocrinol Metab132015e22604
  137. P.AutierM.BoniolC.PizotVitamin D status and ill health: A systematic reviewLancet Diabetes Endocrinol220147689
  138. A.BreslavskyJ.FrandZ.MatasEffect of high doses of vitamin D on arterial properties, adiponectin, leptin and glucose homeostasis in type 2 diabetic patientsClin Nutr322013970975
  139. J.C.SeidaJ.MitriI.N.ColmersClinical review: Effect of vitamin D3 supplementation on improving glucose homeostasis and preventing diabetes: A systematic review and meta-analysisJ Clin Endocrinol Metab99201435513560
  140. D.PapandreouZ.T.HamidThe role of vitamin D in diabetes and cardiovascular disease: An updated review of the literatureDis Markers20152015580474
  141. P.Munoz-AguirreM.FloresN.MaciasThe effect of vitamin D supplementation on serum lipids in postmenopausal women with diabetes: A randomized controlled trialClin Nutr342015799804
  142. T.JafariA.A.FallahA.BaraniEffects of vitamin D on serum lipid profile in patients with type 2 diabetes: A meta-analysis of randomized controlled trialsClin Nutr35201612591268
  143. M.H.EftekhariM.AkbarzadehM.H.DabbaghmaneshThe effect of calcitriol on lipid profile and oxidative stress in hyperlipidemic patients with type 2 diabetes mellitusArya Atheroscler1020148288
  144. J.WainsteinZ.LandauY.Bar DayanPurslane extract and glucose homeostasis in adults with type 2 diabetes: A double-blind, placebo-controlled clinical trial of efficacy and safetyJ Med Food192016133140
  145. K.J.LeeY.J.LeeEffects of vitamin D on blood pressure in patients with type 2 diabetes mellitusInt J Clin Pharmacol Ther542016233242
  146. G.A.LamasC.GoertzR.BoineauEffect of disodium EDTA chelation regimen on cardiovascular events in patients with previous myocardial infarction: The TACT randomized trialJAMA309201312411250
  147. E.EscolarG.A.LamasD.B.MarkThe Effect of an EDTA-based chelation regimen on patients with diabetes mellitus and prior myocardial infarction in the Trial to Assess Chelation Therapy (TACT)Circ Cardiovasc Qual Outcomes720141524
  148. LianF.WuL.TianJ.The effectiveness and safety of a danshen-containing Chinese herbal medicine for diabetic retinopathy: A randomized, double-blind, placebo-controlled multicenter clinical trialJ Ethnopharmacol16420157177
  149. OuJ.Y.HuangD.WuY.S.A meta-analysis of randomized controlled trials of yiqi yangyin huoxue method in treating diabetic nephropathyEvid Based Complement Alternat Med201620163257603
  150. XiangL.JiangP.ZhouL.Additive effect of qidan dihuang grain, a traditional Chinese medicine, and angiotensin receptor blockers on albuminuria levels in patients with diabetic nephropathy: A randomized, parallel-controlled trialEvid Based Complement Alternat Med201620161064924
  151. LiuH.ZhengJ.LiR.H.Clinical efficacy of “Spleen-kidney-care” Yiqi Huayu and Jiangzhuo traditional Chinese medicine for the treatment of patients with diabetic nephropathyExp Ther Med10201510961102
  152. ChenY.Z.GongZ.X.CaiG.Y.Efficacy and safety of Flos Abelmoschus manihot (Malvaceae) on type 2 diabetic nephropathy: A systematic reviewChin J Integr Med212015464472
  153. YangG.ZhangM.ZhangM.Effect of Huangshukuihua (Flos Abelmoschi Manihot) on diabetic nephropathy: A meta-analysisJ Tradit Chin Med3520151520
  154. WangB.ChenS.YanX.The therapeutic effect and possible harm of puerarin for treatment of stage III diabetic nephropathy: A meta-analysisAltern Ther Health Med2120153644
  155. LiP.ChenY.LiuJ.Efficacy and safety of tangshen formula on patients with type 2 diabetic kidney disease: A multicenter double-blinded randomized placebo-controlled trialPLoS ONE102015e0126027
  156. ZhaoJ.Y.DongJ.J.WangH.P.Efficacy and safety of vitamin D3 in patients with diabetic nephropathy: A meta-analysis of randomized controlled trialsChin Med J127201428372843
  157. C.JoergensenL.TarnowJ.P.GoetzeVitamin D analogue therapy, cardiovascular risk and kidney function in people with type 1 diabetes mellitus and diabetic nephropathy: A randomized trialDiabet Med322015374381
  158. M.HeydariK.HomayouniM.H.HashempurTopical citrullus colocynthis (bitter apple) extract oil in painful diabetic neuropathy: A double-blind randomized placebo-controlled clinical trialJ Diabetes82016246252
  159. WuJ.ZhangX.ZhangB.Efficacy and safety of puerarin injection in treatment of diabetic peripheral neuropathy: A systematic review and meta-analysis of randomized controlled trialsJ Tradit Chin Med342014401410
  160. C.I.TsaiLiT.C.ChangM.H.Chinese medicinal formula (MHGWT) for relieving diabetic neuropathic pain: A randomized, double-blind, placebo-controlled trialEvid Based Complement Alternat Med20132013
  161. M.B.KrawinkelG.B.KedingBitter gourd (Momordica Charantia): A dietary approach to hyperglycemiaNutr Rev642006331337
  162. R.R.SimonV.MarksA.R.LeedsA comprehensive review of oral glucosamine use and effects on glucose metabolism in normal and diabetic individualsDiabetes Metab Res Rev2720111427
  163. V.KumarA.JagannathanM.PhilipRole of yoga for patients with type II diabetes mellitus: A systematic review and meta-analysisComplement Ther Med252016104112
  164. K.E.InnesT.K.SelfeYoga for adults with type 2 diabetes: A systematic review of controlled trialsJ Diabetes Res201620166979370
  165. E.de G R HansenK.E.InnesThe benefits of yoga for adults with type 2 diabetes: A review of the evidence and call for a collaborative, integrated research initiativeInt J Yoga Therap20137183
  166. L.W.PaiLiT.C.Y.J.HwuThe effectiveness of regular leisure-time physical activities on long-term glycemic control in people with type 2 diabetes: A systematic review and meta-analysisDiabetes Res Clin Pract11320167785
  167. B.W.TjiptoK.SaputraT.C.SutrisnoEffectiveness of acupuncture as an adjunctive therapy for diabetes mellitus: A randomized controlled trialMed Acupunct262014341345
  168. YangM.LiX.LiuS.Meta-analysis of acupuncture for relieving non-organic dyspeptic symptoms suggestive of diabetic gastroparesisBMC Complement Altern Med132013311
  169. ChenW.YangG.Y.LiuB.Manual acupuncture for treatment of diabetic peripheral neuropathy: A systematic review of randomized controlled trialsPLoS ONE82013e73764
  170. M.S.LeeJ.H.JunH.J.LimA systematic review and meta-analysis of tai chi for treating type 2 diabetesMaturitas8020151423
  171. YanJ.H.GuW.J.PanL.Lack of evidence on Tai Chi-related effects in patients with type 2 diabetes mellitus: A meta-analysisExp Clin Endocrinol Diabetes1212013266271
  172. P.E.WändellJ.ÄrnlövA.Nixon AndreassonEffects of tactile massage on metabolic biomarkers in patients with type 2 diabetesDiabetes Metab392013411417
  173. K.AnderssonP.WändellL.TörnkvistTactile massage improves glycaemic control in women with type 2 diabetes: A pilot studyPract Diabetes Int212004105109
  174. P.E.WändellA.C.CarlssonK.AnderssonTactile massage or relaxation exercises do not improve the metabolic control of type 2 diabeticsOpen Diabetes J32010610
  175. K.DalalV.B.MaranR.M.PandeyDetermination of efficacy of reflexology in managing patients with diabetic neuropathy: A randomized controlled clinical trialEvid Based Complement Alternat Med20142014843036
  176. D.MoherA.LiberatiJ.TetzlaffPreferred reporting items for systematic reviews and meta-analyses: The PRISMA statementPLoS Med62009e1000097
 
Reproduced with permission from Canadian Journal of Diabetes © 2018 Canadian Diabetes Association. To cite this article, please refer to For citation.
 

*The Canadian Diabetes Association is the registered owner of the name Diabetes Canada. All content on guidelines.diabetes.ca, CPG Apps and in our online store remains exactly the same. For questions, contact communication@diabetes.ca.